Compare · SILO vs ZGN
SILO vs ZGN
Side-by-side comparison of Silo Pharma Inc. (SILO) and Ermenegildo Zegna N.V. (ZGN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SILO and ZGN operate in Apparel (Consumer Discretionary), so they compete in similar markets.
- ZGN is the larger of the two at $3.98B, about 39.0x SILO ($101.8M).
- Over the past year, SILO is down 35.0% and ZGN is up 77.3% - ZGN leads by 112.3 points.
- SILO has been more active in the news (2 items in the past 4 weeks vs 1 for ZGN).
- ZGN has more recent analyst coverage (18 ratings vs 0 for SILO).
- Company
- Silo Pharma Inc.
- Ermenegildo Zegna N.V.
- Price
- $6.25+5.57%
- $15.31+3.24%
- Market cap
- $101.8M
- $3.98B
- 1M return
- -2.37%
- +16.34%
- 1Y return
- -35.00%
- +77.30%
- Industry
- Apparel
- Apparel
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 2
- 1
- Recent ratings
- 0
- 18
Ermenegildo Zegna N.V.
Ermenegildo Zegna N.V., together with its subsidiaries, designs, manufactures, markets, and distributes luxury menswear, footwear, leather goods, and other accessories under the Zegna and the Thom Browne brands. It provides luxury leisurewear for men; formal suits, tuxedos, shirts, blazers, formal overcoats, and accessories; leather accessories comprising shoes, bags, belts, and small leather accessories; and fragrances. The company also offers luxury womenswear and childrenswear under the Thom Browne brand, as well as provides eyewear, cufflinks and jewelry, watches, underwear, and beachwear manufactured by third parties under licenses. It serves customers through its retail stores and online channels in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company was founded in 1910 and is based in Trivero, Italy. Ermenegildo Zegna N.V. is a subsidiary of Monterubello Societa' Semplice.
Latest SILO
- Silo Pharma Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- Silo Pharma Inc. filed SEC Form 8-K: Other Events
- Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
- Silo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
- Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
- SEC Form 424B3 filed by Silo Pharma Inc.
- SEC Form EFFECT filed by Silo Pharma Inc.
- SEC Form 424B3 filed by Silo Pharma Inc.
- SEC Form POS AM filed by Silo Pharma Inc.
- SEC Form EFFECT filed by Silo Pharma Inc.
Latest ZGN
- Zegna Group upgraded by TD Cowen with a new price target
- SEC Form SD filed by Ermenegildo Zegna N.V.
- Artistic Director Sartori Alessandro converted options into 31,500 units of Ordinary Shares and sold $85,346 worth of Ordinary Shares (6,505 units at $13.12), increasing direct ownership by 21% to 142,237 units (SEC Form 4) to satisfy withholding tax
- Group Chief Financial Officer Santhia Gian Franco sold $75,676 worth of Ordinary Shares (5,768 units at $13.12) and converted options into 15,600 units of Ordinary Shares, increasing direct ownership by 28% to 44,448 units (SEC Form 4) (tax liability)
- Co-CEO of the ZEGNA brand Zegna Di Monte Rubello Edoardo converted options into 31,500 units of Ordinary Shares and sold $223,525 worth of Ordinary Shares (17,037 units at $13.12), increasing direct ownership by 5% to 304,960 units (SEC Form 4) (for tax liability)
- Acting Group CEO Tagliabue Gianluca Ambrogio sold $250,658 worth of Ordinary Shares (19,105 units at $13.12) and bought 47,250 units of Ordinary Shares, increasing direct ownership by 20% to 167,720 units (SEC Form 4) (withholding obligation)
- Co-CEO of the ZEGNA brand Zegna Di Monte Rubello Angelo converted options into 15,600 units of Ordinary Shares and sold $25,387 worth of Ordinary Shares (1,935 units at $13.12), increasing direct ownership by 11% to 140,112 units (SEC Form 4) to cover withholding tax
- Director Norsa Michele sold $47,480 worth of Ordinary Shares (4,000 units at $11.87), decreasing direct ownership by 2% to 166,348 units (SEC Form 4)
- SEC Form 6-K filed by Ermenegildo Zegna N.V.
- SEC Form 6-K filed by Ermenegildo Zegna N.V.